Summary
We have studied the mechanisms of the increased dosage requirements of the H2-receptor antagonist cimetidine in paediatric burned patients in a pharmacokinetic and pharmacodynamic study.
Cimetidine (10–15 mg·kg−1) was given to 21 burned children and multiple blood samples were obtained for determination of plasma cimetidine concentrations and pharmacokinetic analysis.
The relation of gastric pH to plasma cimetidine concentrations was studied in five of these children who had nasogastric tubes. In an additional four patients the effects of cimetidine on gastric pH were studied during a continuous infusion of cimetidine, which maintained steady-state plasma cimetidine concentrations above 0.5 µg·ml−1.
The mean (SEM) clearance of cimetidine in burned children was 16.22 ml·kg−1 and cimetidine half-life was 1.06 h. The cimetidine clearance and half-life values were significantly higher in burned children compared with our previously reported values for normal adult patients, 8.2 ml·min·kg−1 and 2.21 h respectively.
Endogenous creatinine clearance normalized to 70 kg in burned children was 190 ml·min−1. In burned children 41% of the dose of intact cimetidine was excreted during 8 h of the study compared with 45% excretion during 24 h in healthy adult controls previously reported. The correlation coefficient between creatinine and cimetidine clearances was 0.93 (r 2=0.85).
The plasma concentration of cimetidine needed to increase gastric pH to ≥4.0 was ≥1.0 µg·ml−1, which contrasts with the value of >0.5 µg·ml−1 required for adult burned patients.
These findings support the hypothesis that the higher dosage requirements of cimetidine in burned children is due both to enhanced elimination kinetics and to alterations in target organ sensitivity, requiring higher than normal plasma concentrations for the desired effect. In burned children Cimetidine should be given in higher doses and/or more frequently.
Similar content being viewed by others
References
Czaza AJ, McAlhany JC, Pruitt BA (1974) Acute gastroduodenal disease after thermal injury. N Engl J Med 291: 925–929
Day HB, Macmillan BG, Altemeir WA (1972) Curling's ulcer. Charles C. Thomas, Springfield, IL, pp 180–185
Curling TB (1841) On acute ulceration of duodenum in cases of burn. Med Clin Trans Lond 251: 260–281
Sevitt S (1967) Duodenal and gastric ulceration after burning. Br J Surg 54: 32–41
Moncrief JA (1973) Burns. N Engl J Med 288: 356–456
Pruitt BA, Foley FD, Moncrief JA (1981) Curling's ulcer: A clinical pathological study of 323 cases. Ann Surg 172: 523–539
Silen W, Merhav A, Sinison JNL (1981) The pathophysiology of stress ulcer disease. World J Surg 165–174
Martin LF, Max MH, Polk HC (1980) Failure of gastric pH control by antacid or cimetidine in the critically ill: A valid sign of sepsis. Surgery 88: 59–68
Munster AW (1980) The early management of thermal burns. Surgery 87: 29–39
McElwee HP, Sirinek KR, Levine BA (1979) Cimetidine affords protection equal to antacids in prevention of stress ulceration following thermal injury. Surgery 86: 620–626
Martyn JAJ (1986) Clinical pharmacology and drug therapy in the burned patient. Anesthesiology 65: 67–75
Martyn JAJ (1985) Cimetidine and/or antacid for the control of gastric acidity in pediatric burn patients. Crit Care Med 13: 1–3
Goudsouzian NG, Cote CJ, Liu LMP, Diedrick DF (1981) The dose-response effects of oral cimetidine on gastric pH and volume in children. Anesthesiology 55: 533–536
Priebe HJ, Skillman JJ, Bushness LS, Long PC, Silen W (1980) Antacid versus cimetidine in preventing acute gastrointestinal bleeding: A randomized study in 75 critically ill patients. N Engl J Med 302: 426–430
Martyn JAJ, Greenblatt DJ, Abernethy DR (1985) Increased cimetidine clearance in burned patients. J Am Med Assoc 253: 1288–1291
Lorenzo B, Drayer DH (1981) Improved method for measurement of cimetidine in human serum by reverse phase higher pressure liquid chromatography. J Lab Clin Med 97: 545–550
Harmatz JS, Greenblatt DJ (1987) A simplex procedure for fitting nonlinear pharmacokinetic models. Comput Biol Med 17: 199–208
Gugler R, Fuchs G, Dieckmann M, Somogyi A (1981) Cimetidine plasma-concentration-response relationships. Clin Pharmacol Ther 29: 744–748
Bodemar G, Norlander B, Walan A (1981) Pharmacokinetics of cimetidine after single doses and during continuous treatment. Clin Pharmacokin 6: 306–315
Sheiner LB, Stanski DR, Vozeh S (1979) Simultaneous modeling of pharmacokinetics and dynamics: application to d-tubocurarine. Clin Pharmacol Ther 25: 358–371
Chin TWF, MacLeod SM, Fenje P, Baltodano A, Edmons JF, Soldin SJ (1982) Pharmacokinetics of cimetidine in critically ill children. Pediatr Pharmacol 2: 285–292
Lloyd CW, Martin WJ, Taylor BD, Hauser AR (1985) Pharmacokinetics and pharmacodynamics of cimetidine and metabolites in critically ill children. J Pediatr 107: 295–300
Martyn JAJ, Goldhill DR, Goudsouzian NG (1986) Clinical pharmacology of neuromuscular relaxants in burned patients. J Clin Pharmacol 26: 680–685
Martyn JAJ, Wilson RS, Burke JF (1986) Right ventricular and pulmonary hemodynamics of low dose dopamine in non-septic burned patients. Chest 89: 357–360
Physicians Desk Reference (1988) Medical Economics Co, Oradell, NJ, pp 2031–2034
Somogyi A, Gugler R (1981) Drug interactions with cimetidine. Clin Pharmacokinet 7: 23–41
Ufberg MG, Brook CM, Bosanac PR (1977) Transient neutropenia in a patient receiving cimetidine. Gastroenterology 73: 635–628
Chang KH, Morrison MD (1979) Bone marrow suppression with cimetidine. Ann Intern Med 91: 580
Ostro MJ, Russell JA; Soldin SJ, Mahon WA, Jeejeebhoy KN (1985) Control of gastric pH with cimetidine: Bolus versus primed infusions. Gastroenterology 89: 532–537
Somogyi A, Becker M, Gugler R (1985) Cimetidine pharmacokinetics and dosage requirements in children. Eur J Pediatr 144: 72–76
Ziemniak JA, Assael BM, Padoan R, Schentag JJ (1984) The bioavailability and pharmacokinetics of cimetidine and its metabolites in juvenile cystic fibrosis patients: age related differences as compared to adults. Eur J Clin Pharmacol 26: 183–189
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Martyn, J.A.J., Greenblatt, D.J., Hagen, J. et al. Alteration by burn injury of the pharmacokinetics and pharmacodynamics of cimetidine in children. Eur J Clin Pharmacol 36, 361–367 (1989). https://doi.org/10.1007/BF00558296
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00558296